|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardiovascular safety of the cy- elooxygenase-2 selective inhibitors pareeoxib and valdecoxib in the postoperative setting:an analysis of integrated data显示文摘 | Sehug SA Joshi GP Camu F | 2009 | Auesth Analg2009，108，1： | 1 |
| 2 | DNA methylation chan- ges in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma显示文摘 | Selamat SA Galler JS Joshi AD | 2011 | PLoS One2011，6，21： | 1 |
| 3 | Internal architecture of the talus显示文摘 | Athavale SA Joshi SD Joshi SS | 2008 | Foot Ankle Int2008，29，1： | 1 |
| 4 | Procedure-specific pain management and outcome strategies显示文摘 | Joshi GP Schug SA Kehlet H | 2014 | Best Pract Res Ciin Anaesthesiol2014，28，2： | 1 |
| 5 | Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valde- coxib in the postoperative setting: an analysis of integrated data 显示文摘 | Schug SA Joshi GP Camu F | 2009 | Anesth Analg2009，108，1： | 1 |
| 6 | Alterations in the mitochondrial responses to PENAO as a mechanism ofresistance in ovarian cancer cells显示文摘 | Decollogne S Joshi S Chung SA | 2015 | Gynecol Oncol2015，138，2： | 1 |
| 7 | Cardiovascular safety of the cy-clooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting:an analysis of integrated data显示文摘 | Schug SA Joshi GP Camu F | 2009 | Anesth Analg2009，108，： | 1 |
| 8 | Cardiovascular safety of the cyclooxygenase-2selective inhibitors parecoxib and valdecoxib in the postoperative setting:an analysis of integrated data显示文摘 | Schug SA Joshi GP Camu F | 2009 | Anesth Analg2009，108，1： | 1 |
| 9 | Simultaneous determination of hydrochlorothiazide,quinapril and quinaprilat in human plasma by liquid chromatography-tandem mass spectrometry显示文摘 | PAREKH SA PUDAGE A JOSHI SS | 2008 | J Chromatogr B Analyt Technol Biomed Life Sci2008，873，1： | 1 |
| 10 | Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data显示文摘 | Schug SA Joshi GP Camu F | 2009 | Anesth Analg2009，108，1： | 1 |
| 11 | Pain management strategies for urogynecologic surgery:a review显示文摘 | Collins SA Joshi G Quiroz LH | 2014 | Female Pelvic Med Reconstr Surg2014，20，6： | 1 |
| 12 | Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting: an analysis of integrated data 显示文摘 | Schug SA Joshi GP Camu F | 2009 | Anesth Analg2009，108，1： | 1 |
| 13 | DNA methylation changes in atypical adenomatous hyperplasia,adenocarcinoma in situ,and lung adenocarcinoma显示文摘 | Selamat SA Galler JS Joshi AD | 2011 | Plos One2011，6，21： | 1 |
| 14 | DNA methylation changes in atypical adenomatous hyperplasia,adenocarcinoma in situ,and lung adenocarcinoma显示文摘 | Selamat SA Galler JS Joshi AD | | 0，，06： | 1 |
| 15 | The structure and partial synthesis of delelatine, an alkaloid from Delphinium species 显示文摘 | Ross SA Desai HK Joshi BS | 1988 | Phytochemistry1988，27，： | 1 |
| 16 | Cardiovascular safety of the cy-clooxygenase-2 selective inhibitors parecoxib and valdecoxib in thepostoperative setting:an analysis of integrated data显示文摘 | Schug SA Joshi GP Camu F | 2009 | AnesthAnalg2009，108，1： | 1 |
| 17 | Rivastigmine-loaded PLGA and PBCA nanoparticles : preparation, optimization, character- ization, in vitro and pharmacodynamic studies显示文摘 | Joshi SA Chavhan SS Sawant KK | 2010 | Eur J Pharm Biopharm2010，76，2： | 1 |
| 18 | Origins of the coronary arteries and their significance显示文摘 | Joshi SD Joshi SS Athavale SA | | 0，，： | 1 |
| 19 | Cardiovascular safety of the cyclooxy-genase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting:an analysis of integrated data显示文摘 | Schug SA Joshi GP Camu F | 2009 | Anesth Analg2009，，1： | 1 |
| 20 | Cardiovascular safety of the cyclooxygenase-2 selective inhibitors parecoxib and valdecoxib in the postoperative setting:An analysis of integrated data 显示文摘 | Schug SA Joshi GP Camu F | 2009 | Anesth Analg2009，108，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员